ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
The leading pharmaceutical trade associations in the U.S. and Europe have committed to making more information about drug clinical trials available to researchers, patients, and the public. The agreement comes just weeks after Christopher A. Viehbacher, CEO of the French drugmaker Sanofi and president of the European trade association, questioned the wisdom of increased disclosure requirements proposed by European drug regulators (C&EN, July 1, page 8). The new commitments take effect on Jan. 1, 2014.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X